Csl Behring Llc competitive analysis

Explore Csl Behring Llc's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Aug 27, 2026
Patent NumberPublication DateTitleTotal Oppositions
Oct 29, 2025A1At For Reducing Risk Of Onset Of Acute Graft Versus Host Disease After Hematopoeitic Cell Transplantation1
Apr 10, 2019Method For Purification Of Alpha-1-Antitrypsin1

Latest PTAB cases involving Csl Behring Llc

Discover the latest PTAB cases involving Csl Behring Llc, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Csl Behring Llc with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Aug 27, 2026
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
CSL BEHRING - 74 -
LEEMING13 - - -
OCTAPHARMA88 - -